Analysis of multiple cell reservoirs expressing unspliced HIV-1 gag-pol mRNA in patients on antiretroviral therapy

Por Shults, Keith, Flye-Blakemore, Leanne, Patterson, Bruce K, Elbeik, Tarek
Publicado em 2012

Evaluation of the VACUTAINER PPT Plasma Preparation Tube for Use with the Bayer VERSANT Assay for Quantification of Human Immunodeficiency Virus Type 1 RNA

Por Elbeik, Tarek, Nassos, Patricia, Kipnis, Patricia, Haller, Barbara, Ng, Valerie L.
Publicado em 2005

Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected p...

Por Safrin, S, Elbeik, T, Phan, L, Robinson, D, Rush, J, Elbaggari, A, Mills, J
Publicado em 1994

Simultaneous Runs of the Bayer VERSANT HIV-1 Version 3.0 and HCV bDNA Version 3.0 Quantitative Assays on the System 340 Platform Provide Reliable Quantitation and Improved Work Flo...

Por Elbeik, Tarek, Markowitz, Norman, Nassos, Patricia, Kumar, Uday, Beringer, Scott, Haller, Barbara, Ng, Valerie
Publicado em 2004

Quantitative and Cost Comparison of Ultrasensitive Human Immunodeficiency Virus Type 1 RNA Viral Load Assays: Bayer bDNA Quantiplex Versions 3.0 and 2.0 and Roche PCR Amplicor Mo...

Por Elbeik, Tarek, Charlebois, Edwin, Nassos, Patricia, Kahn, James, Hecht, Frederick M., Yajko, David, Ng, Valerie, Hadley, Keith
Publicado em 2000

Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of...

Por Lathey, J L, Fiscus, S A, Rasheed, S, Kappes, J C, Griffith, B P, Elbeik, T, Spector, S A, Reichelderfer, P S
Publicado em 1994

Multicenter Evaluation of the Performance Characteristics of the Bayer VERSANT HCV RNA 3.0 Assay (bDNA)

Por Elbeik, Tarek, Surtihadi, Johan, Destree, Mark, Gorlin, Jed, Holodniy, Mark, Jortani, Saeed A., Kuramoto, Ken, Ng, Valerie, Valdes, Roland, Valsamakis, Alexandra, Terrault, Norah A.
Publicado em 2004

AUTOIMMUNE MYOCARDITIS: PERIPHERAL BLOOD ARCHITECTONICS AND CLINICAL COURSE FEATURES

Por Z. S. Shogenov, K. A. Akhmedilova, N. N. Kekenadze, M. M. Agirov, O. A. Pronina, B. V. Pinegin, T. Elbeik, L. S. Metelitsa, S. B. Suchkov, P. Kh. Dzhanashiya
Publicado em 2009-10-01

SUBPOPULATIONAL FEATURES OF PERIPHERAL BLOOD CELLS IN THE PATIENTS WITH AUTOIMMUNE MYOCARDITIS: CLINICAL AND PATHOGENETIC ASPECTS

Por N. N. Kekenadze, Z. S. Shogenov, E. V. Kalinina, O. A. Pronina, B. V. Pinegin, M. A. Zemtsova, T. Elbeik, K. A. Maltsev, N. V. Gnuchev, S. V. Suchkov
Publicado em 2014-07-01

SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS

Por V. A. Chumakov, O. A. Pronina, I. A. Kachkov, A. G. Korshounov, B. V. Pineguin, I. I. Anan’eva, T. Elbeik, L. S. Metelitsa, A. E. Dorofeev, N. V. Gnouchev, S. V. Souchkov
Publicado em 2014-07-01